Related Experiment Videos
Angiotensin converting enzyme inhibitors
1Department of Medicine, University of Missouri, Columbia 65212.
American Journal of Hypertension
|April 1, 1990
Summary
Angiotensin converting enzyme (ACE) inhibitors are highly effective and well-tolerated treatments for hypertension. This review details their mechanisms, pharmacology, renal effects, and clinical use in managing high blood pressure.
Area of Science:
- Pharmacology
- Nephrology
- Cardiology
Background:
- Hypertension is a prevalent global health concern requiring effective therapeutic strategies.
- Angiotensin converting enzyme (ACE) inhibitors represent a significant class of antihypertensive medications.
Purpose of the Study:
- To review the proposed mechanisms of action for ACE inhibitors.
- To discuss the pharmacology of currently available ACE inhibitors.
- To evaluate the renal effects, safety, and efficacy of ACE inhibitors in treating hypertensive diseases.
Main Methods:
- Literature review of scientific articles and clinical studies on ACE inhibitors.
- Analysis of pharmacological data, clinical trial results, and safety profiles.
- Synthesis of information regarding mechanisms, renal effects, and therapeutic applications.
Main Results:
- ACE inhibitors demonstrate well-defined mechanisms of action in managing hypertension.
- Captopril, enalapril, and lisinopril are key commercially available ACE inhibitors with distinct pharmacological profiles.
- These agents exhibit favorable renal effects and a strong safety and efficacy profile across various hypertension severities.
Conclusions:
- ACE inhibitors are a cornerstone therapy for mild, moderate, and severe hypertension.
- Their efficacy, tolerability, and beneficial renal effects solidify their dominant role in antihypertensive treatment.
- Continued research and clinical application of ACE inhibitors are crucial for cardiovascular health management.